Show simple item record

dc.contributor.authorHernández-Ramírez, LCen_US
dc.contributor.authorMorgan, RMLen_US
dc.contributor.authorBarry, Sen_US
dc.contributor.authorD'Acquisto, Fen_US
dc.contributor.authorProdromou, Cen_US
dc.contributor.authorKorbonits, Men_US
dc.date.accessioned2018-04-23T13:29:41Z
dc.date.available2018-01-01en_US
dc.date.issued2018-02-06en_US
dc.date.submitted2018-03-01T07:48:45.583Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/36452
dc.description.abstractDespite the well-recognized role of loss-of-function mutations of the aryl hydrocarbon receptor interacting protein gene (AIP) predisposing to pituitary adenomas, the pituitary-specific function of this tumor suppressor remains an enigma. To determine the repertoire of interacting partners for the AIP protein in somatotroph cells, wild-type and variant AIP proteins were used for pull-down/quantitative mass spectrometry experiments against lysates of rat somatotropinoma-derived cells; relevant findings were validated by co-immunoprecipitation and co-localization. Global gene expression was studied in AIP mutation positive and negative pituitary adenomas via RNA microarrays. Direct interaction with AIP was confirmed for three known and six novel partner proteins. Novel interactions with HSPA5 and HSPA9, together with known interactions with HSP90AA1, HSP90AB1 and HSPA8, indicate that the function/stability of multiple chaperone client proteins could be perturbed by a deficient AIP co-chaperone function. Interactions with TUBB, TUBB2A, NME1 and SOD1 were also identified. The AIP variants p.R304* and p.R304Q showed impaired interactions with HSPA8, HSP90AB1, NME1 and SOD1; p.R304* also displayed reduced binding to TUBB and TUBB2A, and AIP-mutated tumors showed reduced TUBB2A expression. Our findings suggest that cytoskeletal organization, cell motility/adhesion, as well as oxidative stress responses, are functions that are likely to be involved in the tumor suppressor activity of AIP.en_US
dc.description.sponsorshipL.C.H.R. was supported by grants from the National Council of Science and Technology and the Secretariat of Public Education from the Mexican Government. C.P. is funded by the Wellcome Trust grant 095605/Z11/Z. M.K. received grants from the Medical Research Council of the United Kingdom, Wellcome Trust, National Institute of Health Research, Barts and The London Charity, Royal Society, and Pfizer.en_US
dc.format.extent9177 - 9198en_US
dc.languageengen_US
dc.relation.ispartofOncotargeten_US
dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.subjectAIPen_US
dc.subjectFIPAen_US
dc.subjectacromegalyen_US
dc.subjectco-chaperoneen_US
dc.subjectquantitative mass spectrometryen_US
dc.titleMulti-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland.en_US
dc.typeArticle
dc.rights.holder(c) Hernández-Ramírez et al. 2018.
dc.identifier.doi10.18632/oncotarget.24183en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29507682en_US
pubs.issue10en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume9en_US
dcterms.dateAccepted2018-01-01en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record